Company Description
CareMax, Inc. provides care and chronic disease management services through physicians and health care professionals.
It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans.
The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States.
It operates multi-specialty medical care centers in Florida, New York, Tennessee, and Texas. The company is headquartered in Miami, Florida.
Country | United States |
Founded | 2011 |
Industry | Health Information Services |
Sector | Healthcare |
Employees | 1,450 |
CEO | Carlos A. de Solo |
Contact Details
Address: 1000 Nw 57th Court, Suite 400 Miami, Florida 33126 United States | |
Phone | 305-686-3912 |
Website | caremax.com |
Stock Details
Ticker Symbol | CMAX |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001813914 |
CUSIP Number | 14171W103 |
ISIN Number | US14171W2026 |
Employer ID | 85-0992224 |
SIC Code | 8050 |
Key Executives
Name | Position |
---|---|
Carlos A. de Solo | Co-Founder, President, Chief Executive Officer and Director |
Kevin C. Wirges | Executive Vice President, Chief Financial Officer and Treasurer |
Alberto R. de Solo | Executive Vice President and Chief Operating Officer |
Erick Anthony Fernandez | Chief Accounting Officer |
Mark Llorente | Chief Administrative Officer and Head of MSO Operations |
Roger Ou | SVice President of Finance and Investor Relations |
Meredith Longsworth | Senior Vice President, General Counsel and Secretary |
Teresa McMeans | Chief Compliance Officer |
Regla Wuilchrist | Chief People Officer |
Niberto Moreno M.D. | Chief Medical Officer and President of Caremax MSO |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 18, 2024 | 8-K | Current Report |
Mar 18, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
Mar 18, 2024 | 10-K | Annual Report |
Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Feb 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Feb 5, 2024 | 8-K | Current Report |
Jan 29, 2024 | 8-K | Current Report |
Jan 11, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Jan 11, 2024 | 8-K | Current Report |
Dec 21, 2023 | DEF 14A | Other definitive proxy statements |